Cellumed Finalizes Investment Coordination for Business Diversification... "Accelerating New Businesses Including Secondary Batteries"

Cellumed announced on the 28th that it is finalizing funding arrangements for business diversification, including new ventures in secondary batteries. Among several investors, the company plans to initially attract an investment of 5 billion KRW from the institution offering the most favorable terms at this time. Cellumed also plans one to two additional rounds of funding depending on future business progress.

With the funds raised this time, Cellumed intends to concretize its secondary battery replaceable battery platform business. Since last year, Cellumed has been preparing for the secondary battery replaceable battery, electric two-wheelers, and battery exchange station businesses. To this end, it signed an MOU with a global Chinese company for supplying secondary battery solutions and is about to finalize the main contract soon.

Cellumed aims to complete the establishment of mass production facilities for secondary battery replaceable batteries and electric two-wheelers within this year and obtain the necessary permits and approvals to achieve full-scale sales starting next year. In the future, the company plans to expand the replaceable secondary battery sector into various mobility fields such as converted electric vehicles, electric ships, and drones.

Moreover, with this investment as a turning point, Cellumed is expected to accelerate its entry into the medical robot field by integrating AI medical robot technology with its self-developed patient-specific implant (PSI) for total joint replacement surgery. Recently, Cellumed not only recruited external experts in the AI medical robot field as outside directors but also established a collaborative system through MOUs with related companies to enhance global competitiveness.

In addition, Cellumed has completed the development of mRNA enzyme samples and plans to expand the scale of its core bio and medical device business by discovering suppliers.

A Cellumed official stated, “During this investment attraction process, we met with several institutional investors, including leading domestic securities firms and asset management companies,” adding, “Most institutions gave positive evaluations of the company’s business diversification efforts, such as the new secondary battery replaceable battery platform business, despite the very challenging investment environment.”

He continued, “Since the first round of investment is ahead of an important contract, we prioritized institutions that could promptly execute funding and offered reasonable terms among various conditions, and we are in the final stages of negotiation,” adding, “The response from institutions has been favorable, so we believe there will be no major issues in securing additional funding for new businesses in the future.”